Exact Mass: 285.1244

Exact Mass Matches: 285.1244

Found 70 metabolites which its exact mass value is equals to given mass value 285.1244, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Leucomethylene blue

N3,N3,N7,N7-tetramethyl-10H-phenothiazine-3,7-diamine

C16H19N3S (285.13)


C26170 - Protective Agent > C1509 - Neuroprotective Agent

   

HC Blue no. 2

2,2-[[4-[(2-Hydroxyethyl)amino]-3-nitrophenyl]imino]bis-ethanol

C12H19N3O5 (285.1325)


   

Isothipendyl

dimethyl(1-{9-thia-2,4-diazatricyclo[8.4.0.0³,⁸]tetradeca-1(14),3(8),4,6,10,12-hexaen-2-yl}propan-2-yl)amine

C16H19N3S (285.13)


Isothipendyl is only found in individuals that have used or taken this drug. It is an antihistamine and anticholinergic used as an antipruritic.Isothipendyl is a selective histamine H1 antagonist and binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AD - Phenothiazine derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

Glycylprolylhydroxyproline

(2S,4R)-1-[(2S)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carboxylic acid

C12H19N3O5 (285.1325)


Glycylprolylhydroxyproline is a tripeptide that has been found in urine and blood serum (PMID 5134921). In growing children, higher level excretion of urinary hydroxyproline peptides (including glycylprolylhydroxyproline) has been observed (PMID 14105582). [HMDB] Glycylprolylhydroxyproline is a tripeptide that has been found in urine and blood serum (PMID: 5134921). In growing children, higher level excretion of urinary hydroxyproline peptides (including glycylprolylhydroxyproline) has been observed (PMID: 14105582).

   

dimethylidenebutanedioylcarnitine

3-[(3-carboxy-2,3-dimethylidenepropanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H19NO6 (285.1212)


dimethylidenebutanedioylcarnitine is an acylcarnitine. More specifically, it is an dimethylidenebutanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. dimethylidenebutanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine dimethylidenebutanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E,4E)-Hexa-2,4-dienedioylcarnitine

3-[(5-carboxypenta-2,4-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H19NO6 (285.1212)


(2E,4E)-hexa-2,4-dienedioylcarnitine is an acylcarnitine. More specifically, it is an (2E,4E)-hexa-2,4-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E,4E)-hexa-2,4-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E,4E)-hexa-2,4-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Prothipendyl

dimethyl(3-{9-thia-2,4-diazatricyclo[8.4.0.0^{3,8}]tetradeca-1(14),3(8),4,6,10,12-hexaen-2-yl}propyl)amine

C16H19N3S (285.13)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics

   

2-(3-(Diallylamino)propionyl)benzothiophene

1-(1-benzothiophen-2-yl)-3-[bis(prop-2-en-1-yl)amino]propan-1-one

C17H19NOS (285.1187)


   

Isoeudistomin U

Isoeudistomin U

C19H15N3 (285.1266)


   

(2-Methyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

(2-Methyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

C20H15NO (285.1154)


   

Mycosporine 2

Mycosporine 2

C13H19NO6 (285.1212)


   

2,4-dimethyl-3-pyrrolylcarbonyl alpha-L-rhamnopyranoside

2,4-dimethyl-3-pyrrolylcarbonyl alpha-L-rhamnopyranoside

C13H19NO6 (285.1212)


   

2,5-Dioxo-3-isopropyl-1H-pyrrole-1-propanoic acid 2,3-dihydroxypropyl ester

2,5-Dioxo-3-isopropyl-1H-pyrrole-1-propanoic acid 2,3-dihydroxypropyl ester

C13H19NO6 (285.1212)


   

iteamine|o-aminobenzyl beta-D-glucopyranoside

iteamine|o-aminobenzyl beta-D-glucopyranoside

C13H19NO6 (285.1212)


   

1-Pyridylhydroxybutyl-hypoxanthine

1-Pyridylhydroxybutyl-hypoxanthine

C14H15N5O2 (285.1226)


   

Glycylprolylhydroxyproline

Glycylprolylhydroxyproline

C12H19N3O5 (285.1325)


   

Isothipendyl

dimethyl(1-{9-thia-2,4-diazatricyclo[8.4.0.0^{3,8}]tetradeca-1(10),3,5,7,11,13-hexaen-2-yl}propan-2-yl)amine

C16H19N3S (285.13)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AD - Phenothiazine derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

Tritylazide

Tritylazide

C19H15N3 (285.1266)


   

9-Benzyl-9H-carbazole-3-carbaldehyde

9-Benzyl-9H-carbazole-3-carbaldehyde

C20H15NO (285.1154)


   

Benzoctamine Hydrochloride

Benzoctamine Hydrochloride

C18H20ClN (285.1284)


   

3-(5-methoxy-6,7,8,9-tetrahydroimidazo[1,2-a]quinazolin-2-yl)-5-methyl-1,2,4-oxadiazole

3-(5-methoxy-6,7,8,9-tetrahydroimidazo[1,2-a]quinazolin-2-yl)-5-methyl-1,2,4-oxadiazole

C14H15N5O2 (285.1226)


   

(S)-4-Benzyl-3-(4-fluorophenyl)morpholin-2-one

(S)-4-Benzyl-3-(4-fluorophenyl)morpholin-2-one

C17H16FNO2 (285.1165)


   

Lanperisone

Lanperisone

C15H18F3NO (285.134)


C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant

   

(4-((((Benzyloxy)carbonyl)amino)methyl)phenyl)boronic acid

(4-((((Benzyloxy)carbonyl)amino)methyl)phenyl)boronic acid

C15H16BNO4 (285.1172)


   

(4-((4-METHOXYBENZYL)CARBAMOYL)PHENYL)BORONIC ACID

(4-((4-METHOXYBENZYL)CARBAMOYL)PHENYL)BORONIC ACID

C15H16BNO4 (285.1172)


   

N-(2-phenylphenyl)-1H-benzimidazol-2-amine

N-(2-phenylphenyl)-1H-benzimidazol-2-amine

C19H15N3 (285.1266)


   

(3aR,5R,5aS,8aS,8bR)-5-(azidomethyl)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydro-3aH-di[1,3]dioxolo[4,5-a:5,4-d]pyran

(3aR,5R,5aS,8aS,8bR)-5-(azidomethyl)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydro-3aH-di[1,3]dioxolo[4,5-a:5,4-d]pyran

C12H19N3O5 (285.1325)


   

BOC-D,L-5,5,5-TRIFLUOROLEUCINE

BOC-D,L-5,5,5-TRIFLUOROLEUCINE

C11H18F3NO4 (285.1188)


   

(2-Methyl-1H-indol-3-yl)(1-naphthyl)methanone

(2-Methyl-1H-indol-3-yl)(1-naphthyl)methanone

C20H15NO (285.1154)


   

(3-((4-Methoxybenzyl)carbamoyl)phenyl)boronic acid

(3-((4-Methoxybenzyl)carbamoyl)phenyl)boronic acid

C15H16BNO4 (285.1172)


   

n,o-bis(diethylhydrogensilyl)trifluoroacetamide

n,o-bis(diethylhydrogensilyl)trifluoroacetamide

C10H22F3NOSi2 (285.1192)


   

1H-Pyrrolo[2,3-b]pyridin-6-amine, 2,3-diphenyl-

1H-Pyrrolo[2,3-b]pyridin-6-amine, 2,3-diphenyl-

C19H15N3 (285.1266)


   

Ethyl 5-(2-(tert-butoxycarbonylamino)ethyl)-1,2,4-oxadiazole-3-carboxylate

Ethyl 5-(2-(tert-butoxycarbonylamino)ethyl)-1,2,4-oxadiazole-3-carboxylate

C12H19N3O5 (285.1325)


   
   

1H-Benz[g]indole-3-carboxaldehyde,2-(2-methylphenyl)-(9CI)

1H-Benz[g]indole-3-carboxaldehyde,2-(2-methylphenyl)-(9CI)

C20H15NO (285.1154)


   

n-(3-n-butoxy-2-hydroxypropyl)iminodiacetic acid monosodium salt

n-(3-n-butoxy-2-hydroxypropyl)iminodiacetic acid monosodium salt

C11H20NNaO6 (285.1188)


   

3,8-DIAMINO-6-PHENYLPHENANTHRIDINE

3,8-DIAMINO-6-PHENYLPHENANTHRIDINE

C19H15N3 (285.1266)


   

Benzyl 4-hydrazinylpiperidine-1-carboxylate hydrochloride

Benzyl 4-hydrazinylpiperidine-1-carboxylate hydrochloride

C13H20ClN3O2 (285.1244)


   

(2S)-2-Amino-4-methyl-1-[(2S)-2-methyl-2-oxiranyl]-1-pentanone trifluoroacetate (1:1)

(2S)-2-Amino-4-methyl-1-[(2S)-2-methyl-2-oxiranyl]-1-pentanone trifluoroacetate (1:1)

C11H18F3NO4 (285.1188)


   

3-Azido-3-deoxy-1,2:5,6-bis-O-(1-methylethylidene)-alpha-D-galactofuranose

3-Azido-3-deoxy-1,2:5,6-bis-O-(1-methylethylidene)-alpha-D-galactofuranose

C12H19N3O5 (285.1325)


   

Benzyl (1-(4-fluorophenyl)cyclopropyl)carbamate

Benzyl (1-(4-fluorophenyl)cyclopropyl)carbamate

C17H16FNO2 (285.1165)


   

Glycyl-hydroxyprolyl-proline

Glycyl-hydroxyprolyl-proline

C12H19N3O5 (285.1325)


   

2-Methyl-1,3-di-4-pyridylisoindole

2-Methyl-1,3-di-4-pyridylisoindole

C19H15N3 (285.1266)


   

2-(4-((2-Aminophenyl)sulfonyl)piperazin-1-yl)ethanol

2-(4-((2-Aminophenyl)sulfonyl)piperazin-1-yl)ethanol

C12H19N3O3S (285.1147)


   

(2S)-2-Amino-4-methyl-1-[(2R)-2-methyloxiranyl]-1-pentanone trifluoroacetate

(2S)-2-Amino-4-methyl-1-[(2R)-2-methyloxiranyl]-1-pentanone trifluoroacetate

C11H18F3NO4 (285.1188)


   
   

2-(3-(Diallylamino)propionyl)benzothiophene

2-(3-(Diallylamino)propionyl)benzothiophene

C17H19NOS (285.1187)


   

9-Carbazolyl-(4-methylphenyl)methanone

9-Carbazolyl-(4-methylphenyl)methanone

C20H15NO (285.1154)


   

4-[(Cyclopropylethynyl)oxy]-6-fluoro-3-isopropylquinolin-2(1H)-one

4-[(Cyclopropylethynyl)oxy]-6-fluoro-3-isopropylquinolin-2(1H)-one

C17H16FNO2 (285.1165)


   

Prothipendyl

Prothipendyl

C16H19N3S (285.13)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics

   

Coformycin(1+)

Coformycin(1+)

C11H17N4O5+ (285.1199)


The conjugate acid of coformycin arising from protonation of the imine nitrogen.

   

dimethylidenebutanedioylcarnitine

dimethylidenebutanedioylcarnitine

C13H19NO6 (285.1212)


   

(2E,4E)-Hexa-2,4-dienedioylcarnitine

(2E,4E)-Hexa-2,4-dienedioylcarnitine

C13H19NO6 (285.1212)


   

2-phenyl-N-[2-(phenylmethylthio)ethyl]acetamide

2-phenyl-N-[2-(phenylmethylthio)ethyl]acetamide

C17H19NOS (285.1187)


   

N-[(2-methylphenyl)methyl]-2-[(4-methylphenyl)thio]acetamide

N-[(2-methylphenyl)methyl]-2-[(4-methylphenyl)thio]acetamide

C17H19NOS (285.1187)


   

1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-(2-fluorophenoxy)ethanone

1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-(2-fluorophenoxy)ethanone

C17H16FNO2 (285.1165)


   

2-Methyl-3,7-diphenylpyrazolo[1,5-a]pyrimidine

2-Methyl-3,7-diphenylpyrazolo[1,5-a]pyrimidine

C19H15N3 (285.1266)


   

Gly-pro-hyp

Gly-pro-hyp

C12H19N3O5 (285.1325)


A tripeptide composed of glycine, L-proline and 3-hydroxy-L-proline units joined in sequence by peptide linkages.

   

3,7-Bis(dimethylamino)phenothiazine

3,7-Bis(dimethylamino)phenothiazine

C16H19N3S (285.13)


   

2-(2-Fluorophenyl)-5-(4-methylpiperidin-1-yl)-1,3-oxazole-4-carbonitrile

2-(2-Fluorophenyl)-5-(4-methylpiperidin-1-yl)-1,3-oxazole-4-carbonitrile

C16H16FN3O (285.1277)


   

N-(8-carboxy-3-oxooctanoyl)-L-homoserine lactone

N-(8-carboxy-3-oxooctanoyl)-L-homoserine lactone

C13H19NO6 (285.1212)


   

1-(4-Trifluoromethylphenyl)-2-methyl-3-pyrrolidino-1-propanone

1-(4-Trifluoromethylphenyl)-2-methyl-3-pyrrolidino-1-propanone

C15H18F3NO (285.134)


   

2-[[(2R)-2-formamido-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-2-formamido-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C9H22N2O6P+ (285.1215)


   

(3-Ethoxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Ethoxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C10H24NO6P (285.1341)


   

2-Aminoethyl (2-hydroxy-3-pentoxypropyl) hydrogen phosphate

2-Aminoethyl (2-hydroxy-3-pentoxypropyl) hydrogen phosphate

C10H24NO6P (285.1341)


   

TRX-0237

Leucomethylene blue

C16H19N3S (285.13)


A member of the class of phenothiazines that is 10H-phenothiazine in which the ring hydrogens at positions 3 and 7 have been replaced by dimethylamino groups. C26170 - Protective Agent > C1509 - Neuroprotective Agent

   
   

(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl 2,4-dimethyl-1h-pyrrole-3-carboxylate

(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl 2,4-dimethyl-1h-pyrrole-3-carboxylate

C13H19NO6 (285.1212)


   

3,4,5-trihydroxy-6-methyloxan-2-yl 2,4-dimethyl-1h-pyrrole-3-carboxylate

3,4,5-trihydroxy-6-methyloxan-2-yl 2,4-dimethyl-1h-pyrrole-3-carboxylate

C13H19NO6 (285.1212)


   

3-{3h,4h,9h-pyrido[3,4-b]indol-1-yl}-1h-indole

3-{3h,4h,9h-pyrido[3,4-b]indol-1-yl}-1h-indole

C19H15N3 (285.1266)